A study showed that a defective TGF-β tumor suppressor pathway contributes to various malignancies, including HCC, but interestingly, activated TGF-β signaling can induce plasticity toward a more mesenchymal state in HCC cell models. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.